Charles River Labs Files 2025 Proxy Statement

Ticker: CRL · Form: DEF 14A · Filed: Apr 2, 2025 · CIK: 1100682

Sentiment: neutral

Topics: proxy-statement, governance, shareholder-meeting

Related Tickers: CRLV

TL;DR

CRLV proxy filed, shareholders vote on board & exec pay soon.

AI Summary

Charles River Laboratories International, Inc. filed its definitive proxy statement on April 2, 2025, for its annual meeting on May 20, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key details regarding director nominations and executive pay packages are expected to be detailed within the full document.

Why It Matters

This filing is crucial for shareholders as it details how the company is run, who is on the board, and how executives are compensated, influencing their voting decisions.

Risk Assessment

Risk Level: low — This is a routine annual filing providing information to shareholders and does not inherently introduce new risks.

Key Players & Entities

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to serve as a definitive proxy statement, providing shareholders with information for the upcoming annual meeting, including details on director nominations, executive compensation, and other matters to be voted upon.

When was this proxy statement filed with the SEC?

This proxy statement was filed with the SEC on April 2, 2025.

What is the date of the shareholder meeting for which this proxy statement is issued?

The shareholder meeting for which this proxy statement is issued is scheduled for May 20, 2025.

Who is the filing company?

The filing company is CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

What is the company's primary business classification according to the filing?

According to the filing, the company's Standard Industrial Classification is SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731].

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 2, 2025 regarding CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing